Assignee
CYTUNE PHARMA
FR·7 granted patents·11 pending applications·12 citations·filing 2014–2023
Top patents by PatentIndex Score
18 records- 0187US10899816B2IL-15 and IL-15Rα sushi domain based immunocytokinesCYTUNE PHARMA·Filed 2018·Granted Jan 26, 2021·4 cites·5 claims
- 0286US10626155B2IL-15 and IL-15R\alpha sushi domain based immunocytokinesCYTUNE PHARMA·Filed 2016·Granted Apr 21, 2020·4 cites·8 claims
- 0379US2024083963A1Il-15 and il-15r\alpha sushi domain based immunocytokinesCYTUNE PHARMA·Filed 2023·Application pending·0 cites
- 0471US11273204B2IL-15 and IL-15RAPLHA sushi domain based immunocytokinesCYTUNE PHARMA·Filed 2014·Granted Mar 15, 2022·2 cites·7 claims
- 0571US10808022B2IL-15/IL-15Ralpha based conjugates purification methodCYTUNE PHARMA·Filed 2015·Granted Oct 20, 2020·1 cites·10 claims
- 0670US11753454B2IL-15 and IL-15R\alpha sushi domain based immunocytokinesCYTUNE PHARMA·Filed 2020·Granted Sep 12, 2023·0 cites·11 claims
- 0765US11401312B2Cytokine derived treatment with reduced vascular leak syndromeCYTUNE PHARMA·Filed 2014·Granted Aug 2, 2022·1 cites·28 claims
- 0860US12060407B2IL-15/IL-15Ralpha based conjugates purification methodCYTUNE PHARMA·Filed 2020·Granted Aug 13, 2024·0 cites·7 claims
- 0959US2022193199A1Il-15 and il-15ralpha sushi domain based modulokinesCYTUNE PHARMA·Filed 2022·Application pending·0 cites
- 1059US2022168395A1Combined pharmaceutical compositionCYTUNE PHARMA·Filed 2022·Application pending·0 cites
- 1159US2024350589A1Il-2/il-15rbetagamma agonist combination with antibody-drug conjugates for treating cancerCYTUNE PHARMA·Filed 2022·Application pending·0 cites
- 1259US2022202904A1Combined pharmaceutical compositionCYTUNE PHARMA·Filed 2022·Application pending·0 cites
- 1358US2024294594A1Interleukin-15 based immunocytokinesCYTUNE PHARMA·Filed 2022·Application pending·0 cites
- 1457US2023183306A1Cytokine derived treatment with reduced vascular leak syndromeCYTUNE PHARMA·Filed 2022·Application pending·0 cites
- 1555US2023398185A1Il-2/il-15r-beta-gamma agonist for treating non-melanoma skin cancerCYTUNE PHARMA·Filed 2021·Application pending·0 cites
- 1655US2023390361A1Il-2/il-15r-beta-gamma agonist for treating squamous cell carcinomaCYTUNE PHARMA·Filed 2021·Application pending·0 cites
- 1747US2022241375A1Il-2/il-15r beta gamma agonist dosing regimens for treating cancer or infectious diseasesCYTUNE PHARMA·Filed 2020·Application pending·0 cites
- 1845US2016184399A1Combined pharmaceutical compositionCYTUNE PHARMA·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CYTUNE PHARMA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →